Immune Therapeutics, Inc. Business Finance Contracts & Agreements

47 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Promissory Note between Immune Therapeutics, Inc. and Ira Gaines dated November 4, 2022
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2023
Convertible Promissory Note in the Principal Amount of $200,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2022
Convertible Promissory Note in the Principal Amount of $100,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2022
Convertible Promissory Note in the Principal Amount of $100,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2022
Term Sheet
Term Sheets
Immune Therapeutics, Inc.
Biotechnology
2022
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Robert J. Dailey
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Note Exchange Agreement dated March 31, 2021 between Immune Therapeutics, Inc. and Global Reverb Corporation and Robert J. Dailey
Exchange Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Note Assignment dated November 10, 2020 between Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Note Purchase Agreement dated November 10, 2020 entered into by Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Robert J. Dailey
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Note Exchange Agreement dated March 31, 2021 between Immune Therapeutics, Inc. and Global Reverb Corporation and Robert J. Dailey
Exchange Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Note Assignment dated November 10, 2020 between Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Note Purchase Agreement dated November 10, 2020 entered into by Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Amendment to the Articles of Incorporation filed March 12, 2020 approving an increase in authorized shares of common stock from 500,000,000 to 750,000,000
Stock Agreements
Immune Therapeutics, Inc.
Biotechnology
2020
Amendment to the Articles of Incorporation filed February 5, 2020 approving a reverse split of issued and outstanding shares of common stock by 1,000 to 1
Stock Agreements
Immune Therapeutics, Inc.
Biotechnology
2020
Securities Purchase Agreement dated as of June 15, 2020 with Geneva Roth Remark Holdings, Inc, together with Exhibit A Convertible Promissory Note in the principal amount of...
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement dated as of May 4, 2020 with Geneva Roth Remark Holdings, Inc, together with Exhibit A Convertible Promissory Note in the principal amount of $53,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2020
Convertible Promissory Note dated March 30, 2020 to Redstart Holdings Corp. in the principal amount of $53,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2020
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2020
Mutual Release and Non-Disparagement Agreement effective April 30, 2020
Release Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2020
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2019
Letter to Shareholders
Shareholders Agreements
Immune Therapeutics, Inc.
Biotechnology
2019
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2019
Stock Agreement
Stock Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2018
Loan agreement and promissory note with Rogoff Family Trust, dated February 13, 2018, for $50,000
Loan Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2018
Loan agreement and promissory note with Joel Yanowitz, dated January 9, 2018, for $50,000
Loan Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2018
Iliad Research and Trading (i) promissory note and (ii) warrant dated October 25, 2017
Warrant Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Securities Purchase Agreement dated October 25, 2017 with Iliad Research and Trading, L.P
Purchase Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Securities Purchase Agreement and Warrant dated May 1, 2017 with Ira Gaines
Warrant Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Promissory Note dated April 5, 2017 to Robert J. Dailey in the principal amount of $150,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Promissory Note dated February 6, 2017 issued to Phoenix Fund Management, LLC
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Securities Purchase Agreement and related agreements with JMJ Financial dated April 12, 2016 (filed as Exhibit 10.1 to our Current Report 8-K on April 18, 2016, and incorporated...
Purchase Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Intellectual Property Assignment Agreement with Cytocom, Inc. dated September 4, 2015
Assignment Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Promissory Note Settlement Agreement, dated September 26, 2014, between Immune Therapeutics, Inc. and Robert Dailey for notes equaling $400,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Promissory Note Settlement Agreement, dated September 26, 2014, between Immune Therapeutics, Inc. and Robert Dailey for notes equaling $399,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Securities Purchase Agreement and Note with Iliad Research & Trading LP dated October 20, 2017
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2017
ADDENDUMTO COMMONSTOCK PURCHASE WARRANT DOCUMENTW-04122016
Warrant Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2016